Improving kidney health for girls and women with glomerular kidney disease
CureGN
This project follows girls and women with glomerular kidney disease over time to learn what helps them get better care and avoid kidney failure, with extra attention to Black women and people in rural areas.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11381243 on NIH RePORTER |
What this research studies
If you join, researchers will collect your medical history, treatment records, lab results, and may ask for blood or urine samples and genetic testing (for example APOL1). They will track symptoms, treatments such as ACE inhibitors, blood pressure, and life events like menopause over months and years. The team will compare outcomes across groups by race, location, and other factors to find barriers to good care and what treatments work best. Results will be used to design solution-oriented approaches to reduce disparities and improve care for women and girls with glomerular kidney disease.
Who could benefit from this research
Good fit: Girls and women diagnosed with primary glomerulonephropathy (GN) who are willing to share medical records, provide samples, and participate in regular follow-up are ideal candidates.
Not a fit: People without glomerular kidney disease, men, or anyone unable to participate in long-term follow-up are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, this work could lead to better-targeted care and programs that reduce progression to end-stage kidney disease among women, especially Black and rural patients.
How similar studies have performed: Longitudinal cohorts like the parent CureGN study have produced useful findings about GN and its treatments, and this supplement builds on that existing work.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Mariani, Laura H — University of Michigan at Ann Arbor
- Study coordinator: Mariani, Laura H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.